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Abstract 
Background: As part of a targeted malaria elimination project, mass drug administrations (MDAs) were conducted 
in Vietnam. The impact of MDAs on malaria transmission depends largely on the efficacy of the anti‑malarial drug regi‑
men, the malaria epidemiology in the site and the population coverage. To explore why some people participate in 
MDAs and others do not, a quantitative survey of the villagers’ perceptions was undertaken in Vietnam.
Methods: In 2013/2014 MDAs were conducted in a village in Binh Phuoc province and a village in Ninh Thuan prov‑
ince. Within three months of the drug administration, 59 respondents in a village in Binh Phuoc and 79 respondents in 
a village in Ninh Thuan were randomly selected and interviewed.
Results: Comprehension of the purpose of the intervention was of paramount importance for participation in the 
intervention. Respondents aware that the intervention aims to protect against malaria were significantly more likely to 
participate than respondents who were unaware of the MDA’s purpose. Secondly, how and by whom villagers were 
informed was critical for participation. There was a strong association between sensitization by an informant such as a 
member of the local health team with participation in the intervention.
Conclusions: The study suggests several approaches to increase participation in mass drug administration cam‑
paigns. Training trustworthy informants to sensitize the study population is critical to maximize village participation in 
this setting. To achieve high coverage the entire community must understand and agree with the intervention.
Keywords: Malaria, Plasmodium falciparum, Plasmodium vivax, Mass drug administration, South‑East Asia, Vietnam, 
Knowledge, Attitude, Perceptions, Quantitative survey
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Background
With the growing threat of multidrug resistance in 
the Greater Mekong subregion, the international 
malaria community is recognizing the need for addi-
tional measures, including mass drug administrations 
(MDAs) as a component of rapid malaria elimination 
efforts [1]. Although their popularity has gone through 
cycles, MDAs have been used for malaria control and 
elimination for more than a century [2]. The impact of 
MDAs on malaria transmission is variable [3]. Effective-
ness depends on the efficacy of the anti-malarial drug 
regimen and the proportion of the population partici-
pating [4]. The duration of the impact depends to a large 
part on local malaria epidemiology. While there is an 
extensive literature on the efficacy of anti-malarial drugs, 
information on how to achieve maximum coverage is 
limited.
A recent literature review found 28 detailed descrip-
tions of community engagement in anti-malarial mass 
administrations over the last 100  years [5]. Despite the 
heterogeneity in populations, community engagement 
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and study methods, the authors identified several com-
monalities. The top-down approach based on hierarchical 
structures such as government, village leaders and village 
elders was traditionally relied-on to mobilize the popu-
lations. The use of authority which for example could be 
relied on during smallpox eradication campaigns [6] has 
become less popular and less successful. Instead inves-
tigators depend more on a bottom-up approach based 
on the targeted community itself [7]. The authors of the 
review concluded that both approaches top-down and 
bottom-up are essential for success [5]. The most suc-
cessful campaigns invested in a two-pronged approach by 
engaging the leaders of the targeted communities as well 
as the community members themselves. A better under-
standing what makes a successful campaign would be 
helpful for the design of future campaigns.
As part of a targeted malaria elimination (TME) pro-
ject, MDAs were conducted in two villages in Vietnam. 
The aim of the present study was to identify factors asso-
ciated with MDA participation among a random sample 
of community members in two villages.
Methods
Study site
Despite a substantial reduction in the incidence of malaria 
over the last twenty years in Vietnam the disease remains 
a public health challenge. Since 2010, studies in Binh 
Phuoc province show an increased proportion of slow-
clearing artemisinin-resistant infections [8], but cure 
rates using ACT (dihydroartemisinin–piperaquine) are 
still satisfactory in 2014 [9]. Two villages in Dak O com-
mune, Binh Phuoc province and two villages in Phuoc ha 
Commune, Ninh Thuan province were selected based on 
parasite prevalence, enthusiasm of villagers to participate, 
and access (road conditions) (Fig. 1). Restricted randomi-
zation was used to determine which villages in each prov-
ince received the intervention, MDA in the first year and 
which village would serve as control. The control villages 
also received MDA after one year of surveillance but no 
interviews were conducted in control villages. The names 
and precise co-ordinates of the study villages are withheld 
by the authors to protect the confidentiality of the study 
participants. The MDAs were carried-out in collabora-
tion with the malaria control programme of Vietnam, the 
Institute of Malariology, Parasitology, and Entomology 
(IMPE), Ho Chi Minh City and IMPE, Qui Nhon.
Community engagement
The project was discussed with representatives of the 
health authority, sequentially at the provincial, district, 
commune and village level. Village meetings were con-
vened by the local study investigators, the commune 
health workers and the Peoples Committee staff to plan 
the intervention and to obtain consent from the vil-
lagers. This was followed by house-to-house visits by 
study investigators and the community health workers 
to explain the purpose of the campaigns. The commune 
health workers are living in villages in malaria endemic 
areas and are trained in malaria case detection and man-
agement. The commune health workers received addi-
tional, specific training before the study was conducted 
to be able to provide adequate information on malaria to 
the participants. Banners and posters were used to adver-
tise the campaigns. The campaign was also announced on 
local radio stations. Participants received non-monetary 
incentives such as sweets and rice. Elements of the com-
munity engagement campaign are illustrated in three 
photographs (Figs. 2, 3, 4).
Fig. 1 Map of Vietnam indicating the location of the two provinces 
(Binh Phuoc and Ninh Thuan) where the study was conducted
Fig. 2 Examples of community engagement; house to house visits to 
inform residents about the planned campaign. ©Nguyen Thuy‑Nhien
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The mass drug administration
The rational and the methodology for the mass drug 
administrations have recently been described [4, 10]. The 
drug regimen comprised three rounds of anti-malarial 
drugs one month apart (Fig. 5). Each round consisted of 
three daily doses of DHA/piperaquine combined with a 
single low dose primaquine (15 mg or 0.25 mg/kg). Each 
resident was encouraged to take part in three rounds, 
which constituted a total of nine DHA/piperaquine doses 
over the course of three months plus a single dose of pri-
maquine at each round based on the following rationale. 
DHA remains a powerful, short-acting anti-malarial effec-
tive against most P. falciparum strains. Piperaquine mops 
up surviving parasites and prevents re-infection for the 
following 30 days, at which time the next round of TME 
is administered [11, 12]. Three doses DHA/piperaquine 
are needed to clear a Plasmodium falciparum infection. 
A minimum of three rounds is thought to be needed to 
interrupt malaria transmission, as infectious mosquitoes 
may survive 30 days and infect previously treated people. 
Furthermore, some community members may be absent 
during the drug administration and are thus treated dur-
ing subsequent rounds [13–16]. A single low dose pri-
maquine is sufficient to clear rapidly gametocytes, which 
are not susceptible to schizontocidal drugs [15]. All drugs 
were administered under direct observation by the study 
staff at a central location. The drug administrations were 
embedded within several malaria elimination strategies 
including community engagement, improved case man-
agement, and vector control strategies.
Data collection
A questionnaire used in a survey following a MDA in 
West Africa was adapted to the local context and trans-
lated into Vietnamese [17]. The interview guide and 
questionnaire are included in the Additional file  2. The 
instrument included a set of questions that explored 
opinions and knowledge related to malaria and its con-
trol. Interviewers were trained to administer the instru-
ment in a neutral fashion to minimise bias towards 
preferred responses. At both villages, the interviews were 
completed within three months of the completion of the 
Fig. 3 Examples of community engagement; distribution of rice to 
study participants. ©Nguyen Thuy‑Nhien
Fig. 4 Examples of community engagement; children entertainment 
during a community meeting. ©Nguyen Thuy‑Nhien
Fig. 5 A schematic representation of treatment regimen in targeted malaria elimination (TME). Each drug administration consisted of three rounds, 
1 month apart, of three doses of DHA/piperaquine. A single, low dose primaquine was administered with each round of anti‑malarial drugs
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MDAs. A sample of participants and non-participants 
were randomly selected from the database collected 
during the MDA. Due to an expected correlation in the 
answers from multiple members of a household only one 
person was interviewed per household. To be eligible, 
he or she had to be over 18 years of age, residing in the 
village at the time of the MDA and consent to be inter-
viewed. A study physician who had neither participated 
in the engagement campaign nor the drug administration 
conducted the interviews.
Data management and analysis
The questionnaires were single-entered into a database 
and checked for consistency. Inconsistent data were veri-
fied and corrected. The data were merged with a dataset 
recording the participation in the MDA. Residents who 
took zero MDA doses are defined for the purposes of 
the analysis as “non-participants”, residents who took at 
least one but less than nine doses are defined as “partial-
participants”, and residents who took all nine doses are 
defined as “full-participants”. Interviewees are referred to 
as respondents. The administration of a single low dose 
primaquine with the third dose DHA/piperaquine dur-
ing each round was not included in this analysis. In the 
initial analysis, socio-economic and demographic charac-
teristics were explored to explain differences in degrees 
of participation. Comparisons of categorical data were 
made using Fisher’s exact or Pearson Chi squared test as 
appropriate. Continuous data were compared using Stu-
dent’s t test or in the case of more than two categories, 
with Kruskal–Wallis equality-of-populations rank test. 
Considering the large number of variables and hypoth-
eses tested only a conservative p-value  <0.01 was con-
sidered significant. A logistic regression model was used 
to test the association between predisposing variables 
and the outcome (non-participant vs. participant i.e. ≥1 
dose anti-malarials). Terms that appeared thematically 
relevant and/or were significant in the univariate analysis 
were explored in the model. In the final model, only vari-
ables significant below p < 0.01 were retained, namely lit-
eracy, knowledge of the causes of malaria, recall of being 
informed about the MDA, who explained the MDA, 
comprehension of the rationale and finally the purpose 
for the MDA. Statistical analyses were performed using 
Stata 14.1 (StataCorp LP, College Station, TX, USA).
Results
The MDAs were conducted from November 2013 to 
January 2014 in Binh Phuoc and from January 2014 to 
March 2014 in Ninh Thuan. The interviews were con-
ducted in Binh Phuoc in February and March of 2014 
and in Ninh Thuan in May and June 2014. In Binh Phuoc 
55 participants and 55 non-participants were invited to 
join the interview and in Ninh Thuan 57 participants 
and 39 non-participants. Of the 206, 138 agreed to be 
interviewed (59 in Binh Phuoc and 79 in Ninh Thuan). 
69 (50%) had taken the complete drug regimen of 9 
doses, 22 (16%) participated but did not take the entire 
course and 47 (34%) respondents did not take any dose 
at all. In the village in Binh Phuoc 17 of 59 respondents 
(29%) and in Ninh Thuan 30 of 79 respondents (38%) 
did not participate at all in the MDA. The majority of 
respondents in Ninh Tuan (48/79; 61%) had participated 
in all three rounds (9 doses) and 36% (21/59) in Binh 
Phuoc (p  =  0.097). There was a statistically significant 
difference in the number respondents who only took a 
partial course 21/59 (36%) in Binh Phuoc in contrast to 
only 1/79 (1%) in Ninh Thuan (p < 0.0001; Table 1). The 
study explored the association between a range of demo-
graphic variables with participation (Table  1). There 
was a significant association between residency (having 
always lived in the study village), ethnic group (Raglai 
and Kinh), literacy and religion with degree of partici-
pation in the MDA. Whereas age group, marital status, 
occupation, and having children did not seem to influ-
ence participation.
Respondents were asked which diseases cause the most 
health problems in their village. The relationship between 
the perception which diseases cause the most health 
problems in the village and participation is illustrated in 
Fig. 6. 49/69 (71%) of the respondents who took the full 
course of 9 doses stated that malaria causes most prob-
lems in the village followed by diarrhoea, general pain 
and respiratory tract infections. There was general agree-
ment that relative to the other diseases, malaria caused 
the most health problems (p = 0.449) but the percentage 
who thought that malaria was the biggest problem was 
lower among the partial- 8/22 (36%) and non-partici-
pants 26/47 (55%) compared with the full participants 
(p = 0.491).
Independent of participation status, over 90% of the 
respondents stated that they used bed nets to prevent 
malaria. Keeping the household clean, insecticides and 
mosquito coils were less frequently mentioned. Partial-
participants were more likely to mention cleanliness 
or insecticides compared to non- and full-participants 
(Additional file 1: Figure S1). The most frequently men-
tioned symptoms associated with malaria were in 
decreasing order headache, shivering and fever (Addi-
tional file 1: Figure S2). 6/47 (13%) non-participants men-
tioned fever as a symptom of malaria in contrast to 20/69 
(29%) full-participants (p  =  0.119). When asked about 
the causes of malaria the non-participants were less likely 
to respond that mosquitoes transmit malaria (p = 0.010) 
and more likely to respond “don’t know” (p  =  0.005) 
compared to partial- and full participants (Fig. 7).
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Non-participants were significantly less likely to 
respond that they heard about the MDA from the district 
health team (p < 0.001) and more likely to respond that 
they could not recall if they were informed (p =  0.001) 
than partial- and full participants (Fig.  8). None of the 
respondents reported to have received information 
about the MDAs by the banners, flyers or through other 
villagers.
Important concepts regarding the transmission of 
malaria were understood by a much larger percentage 
of full-participants compared to non-participants. For 
example, 55/69 (80%) respondents who took the com-
plete course agreed that malaria is transmitted by mos-
quitoes from one individual to another in contrast to only 
14/47 (30%) non-participants (p  <  0.001). The critical 
concept of subclinical parasite infections was understood 
by only about half of the full participants 37/69 (54%) 
and even fewer (8/47 or 17%) of the non-participants 
(p = 0.009; Fig. 9). The large majority of respondents did 
not believe that mosquitoes become infected from biting 
infected people who were asymptomatic.
The message that it is important that everyone in the 
village takes the anti-malarial drugs had been understood 
by over 80% of the respondents irrespective of the num-
ber of doses taken. A similar percentage thought there 
would be less malaria following the campaign. The con-
cept that the campaign could protect against malaria was 
accepted by 80% (55/69) of the respondents who took the 
complete course but only 12/46 (26%) of the non-partici-
pants (p < 0.0001). Importantly, none of the respondents 
felt that the anti-malarial drugs should replace the need 
for a bed net (Fig. 10).
Non- and partial-participants were asked why they 
didn’t participate. As shown in Fig. 11 by far the most fre-
quent reported reason for non-participation was travel.
A univariate analysis of 15 variables found that 6 were 
highly significantly associated with participation in the 
MDA (Table 2). Only one variable was found to be inde-
pendently and significantly associated with participation. 
Whether participants could recall being informed about 
the MDA remained highly significant after adjusting for 
other variables. This remained the single independently 
significant variable in an alternative model when compar-
ing full-participants with partial- and non-participants.
Table 1 Characteristics of the 138 respondents
Number (%) by participation p value
Non Partial Full Total
0 doses 1–8 doses 9 doses
n 47 (34%) 22 (16%) 69 (50%) 138 (100%)
Village <0.001
 VN10 Binh 
Phuoc
17 (29%) 21 (36%) 21 (36%) 59 (100%)
 VN 30 Ninh 
Thuan
30 (38%) 1 (1%) 48 (61%) 79 (100%)
Residency <0.001
 Always lived 
in study 
village
37 (33%) 12 (11%) 64 (57%) 113 (100%)
 Relocated into 
study village
9 (38%) 10 (42%) 5 (21%) 24 (100%)













  Raglai 30 (39%) 1 (1%) 46 (60%) 77 (100%)
 S’Tieng 8 (22%) 11 (30%) 18 (49%) 37 (100%)
 Kinh 9 (41%) 8 (36%) 5 (23%) 22 (100%)
 Others 0 (0%) 2 (100%) 0 (0%) 2 (100%)
Marital status 0.108
 Married 36 (31%) 19 (16%) 61 (53%) 116 (100%)
 Single 7 (44%) 1 (6%) 8 (50%) 16 (100%)
 Widow/er 3 (100%) 0 (0%) 0 (0%) 3 (100%)
 NA 1(33%) 2 (67%) 0 3 (100%)
Can read and write? 0.007
 Yes 18 (24%) 16 (21%) 42 (55%) 76 (100%)
 No 27 (47%) 4 (7%) 27 (46%) 58 (100%)
 NA 2 (50%) 2 (50%) 0 4 (100%)
Occupation 0.168
 Farmer 36 (31%) 16 (14%) 63 (55%) 115 (100%)
 Labourer 5 (46%) 4 (36%) 2 (18%) 16 (100%)
 Manufactur‑
ing
1 (50%) 1 (50%) 0 (0%) 2 (100%)
 Professional 2 (50%) 0 (0%) 2 (50%) 4 (100%)
 Retired 1 (100%) 0 (0%) 0 (0%) 1 (100%)
 Trader 0 (0%) 0 (0%) 2 (100%) 2 (100%)
 NA 2 (67%) 1 (33%) 0 3 (100%)
Religion 0.004
 None 35 (39%) 5 (6%) 50 (56%) 90 (100%)
 Christian 4 (18%) 7 (32%) 11 (50%) 22 (100%)
 Buddhist 5 (36%) 4 (29%) 5 (36%) 14 (100%)
 Ancestor wor‑
ship
2 (29%) 3 (43%) 2 (29%) 7 (100%)
 No response 0 (0%) 3 (75%) 1 (25%) 4 (100%)
 Other 1 (0%) 0 (0%) 0 (0%) 1 (100%)
Do you have children? 0.762
 Yes 37 (33%) 18 (16%) 59 (52%) 114 (100%)
 No 9 (39%) 4 (17%) 10 (44%) 23 (100%)
NA no answer/not available, IQR inter quartile range
Table 1 continued
Number (%) by participation p value
Non Partial Full Total
0 doses 1–8 doses 9 doses
 NA 1 (100%) 0 0 1 (100%)
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Fig. 6 Perception of which diseases cause the most health problems in the village, by the number of doses ingested (more than one response was 
permitted)
Fig. 7 Perceptions of what causes malaria, by the number of doses ingested (more than one response was permitted)
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Discussion
The study found that the pivotal difference between par-
ticipation and non-participation in the MDA was the 
recollection of being adequately informed about the 
campaign. Villagers who recalled being informed about 
the campaign were much more likely to participate than 
those who did not. Specifically, residents who had been 
explained about the MDA by the local health team were 
significantly more likely to complete the entire course 
of the drug administration. More qualitative interviews 
would be needed to explore whether trust or multiple fac-
tors beyond trust influenced these decisions. A detailed 
and locally-appropriate explanation of anti-malarial drug 
administration campaigns is needed for an understand-
ing of the complex concepts of malaria transmission, 
the role of subclinical infections in malaria transmission 
and ultimately the acceptance of interventions to inter-
rupt transmission. Demographics also played a role in 
participation; village residency, older age, ethnicity, reli-
gion and literacy were associated with participation. In 
contrast, the occupation of the respondents (most of 
whom were farmers) and whether they had children did 
not make a significant difference in participation.
This study relied on recollection and opinions which 
may be biased and inaccurate. This is illustrated by the 
stated reason for non-participation. Nearly 45% of the 
non-participants said that they were travelling at the 
time of the MDA. When untrue, this response may have 
allowed the respondent and the interviewers to “save 
face”; to spare the interviewer, as well as the respond-
ent, the embarrassment of stating the real reason for 
non-participation. Although none of the respondents 
suggested absence of trust in the researchers or a dis-
like for the drugs as reasons for non-participation, this 
does not necessarily exclude such perceptions. To get 
a more detailed understanding of the true reasons for 
Fig. 8 Response to how he/she heard about the MDA, by the number of doses ingested (more than one response was permitted)
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incomplete or non-participation including deeper moti-
vations, fears and apprehension, in-depth interviews and 
focus group discussions will be needed [18, 19]. A second 
limitation of this study is that the interviews were con-
ducted only in two villages after MDA and with a limited 
number of respondents. A larger number of respond-
ents would potentially increase the generalizability of the 
findings. Nevertheless, the study had sufficient statisti-
cal power to detect differences between full, partial, and 
non-participation.
The findings underscore the importance of community 
mobilization prior to drug administration campaigns and 
could inform how campaigns can be implemented in an 
effective way to maximize participation. The study pro-
vides evidence about the importance not only of what 
information is disseminated but where the information 
comes from. Messages, which made an impact, came 
from a trusted familiar source of heath information. It 
may be necessary to invest time and money to establish 
such core information providers to sensitize the entire 
community appropriately long before an anti-malarial 
drug administration campaign is undertaken. Research 
is under way to better understand which means of com-
munication to explain the underlying concepts and 
Fig. 9 Response to what he/she understood about the MDA, by the number of doses ingested (more than one response was permitted)
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purpose of MDA. It is also important to identify demo-
graphic strata that are less likely to participate and special 
efforts should be undertaken to engage this subgroup of 
the community. In the study villages, it would have been 
worthwhile to specifically visit and engage members of 
two ethnic groups, Raglai and Kinh. The demographic 
data also suggest that it may be worthwhile to take 
extra efforts to include younger, less educated and more 
recently arrived members of the community to treat all 
members of the community.
The findings from this study are consistent with 
recently published findings from a quantitative study fol-
lowing four mass administrations of anti-malarial drugs 
along Thai-Myanmar border areas [20]. While the find-
ings in two of the four villages were comparable to the 
findings reported here the other two villages had issues 
which resulted in fragmented communities suggesting 
that a cohesive community is a helpful if not essential 
predisposition for successful mass drug administrations. 
Several qualitative and quantitative studies following 
anti-malarial mass administrations were conducted in 
The Gambia, West Africa. There the researchers found 
travel, perceived adverse drug reactions and rumours, 
inconveniences related to the logistics of MDA (e.g. wait-
ing times) and the perceived lack of information about 
MDA were critical reasons for non-participation [17, 21, 
22]. While the research into factors related to the par-
ticipation in mass administrations of anti-malarial drugs 
is somewhat limited there is a broad experience how to 
engage communities in other biomedical interventions 
including interventions against the transmission of HIV, 
tuberculosis, and vector-borne disease [23]. This body of 
work has resulted in a framework for community engage-
ment in global health research which has applicability 
for MDAs. Lavery and co-workers suggest twelve points 
to consider for effective community engagement. The 
Fig. 10 Response to what he/she thinks the medicine given during the MDA is for by the number of doses ingested (more than one response was 
permitted)
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provision of information and the building of trust feature 
prominently in the framework suggesting some universal 
principals which have to be respected for successful com-
munity engagement [24].
Conclusions
The elimination of malaria poses large challenges as all 
community members, not only high risk groups have to 
participate in interventions. The findings from this study 
suggest several approaches to maximize participation in 
mass drug administration campaigns and thereby contrib-
ute to a broader understanding what makes community 
engagement successful. The concepts underlying anti-
malarial mass administration are complex and need time 
to be explained especially if the target population has only 
a primary education or less. In the absence of a detailed 
understanding of the rationale the residents in the target 
villages must be able to trust the people providing informa-
tion about the campaign. Training and investing into the 
establishment of a trustworthy team to sensitize the study 
Fig. 11 Response of non‑participants to why he/she did not take the medicine, by the number of doses ingested (more than one response was 
permitted)
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Table 2 Adjusted odds ratios of 138 respondents for variables associated with participation in the MDA
Non-participants are defined as not having taking any doses of the antimalarial drug (DHA/piperaquine). Participants have taken at least one or more doses
adj* adjusted for the statistically significant terms in the crude odds ratio [Literacy, Doesn’t know causes of malaria, Doesn’t recall being told about the MDA, Who 
explained MDA (DHT), Believes everybody should participate in the MDA, Believes the medicine protects against malaria]
OR odds ration, DHT district health team
Non-participants Partial and full participants OR crude p value OR adj* p value
n 47 (34%) 91 (66%)
Sex (male) 34 (37%) 58 (63%) 1.488 0.311 2.580 0.082
Ethnicity (S’Tieng) 8 (22%) 29 (78%) 2.280 0.066 4.594 0.016
Village (VN30) 17 (29%) 42 (72%) 1.513 0.262 2.808 0.098
Median age in years (IQR) 34 (28–46) 37 (27–48) 1.007 0.632 1.022 0.252
Occupation (Farmer) 36 (31%) 79 (69%) 1.795 0.235 1.635 0.428
Literacy 18 (24%) 58 (76%) 2.807 0.006 1.400 0.506
Religion (Christian) 42 (34%) 82 (66%) 1.085 0.890 1.497 0.616
Recent immigration 34 (32%) 72 (68%) 1.449 0.372 1.560 0.469
Believes that malaria is the village’s main health problem 26 (31%) 57 (69%) 1.354 0.406 0.739 0.567
Believes fever is a symptom of malaria 6 (21%) 23 (79%) 2.311 0.093 1.691 0.394
Doesn’t know causes of malaria 33 (29%) 83 (72%) 4.402 0.002 1.593 0.481
Doesn’t recall being told about the MDA 22 (21%) 84 (79%) 13.636 <0.001 7.083 0.001
Who explained MDA (DHT) 11 (15%) 63 (85%) 7.364 <0.001 1.401 0.648
Believes everybody should participate in the MDA 8 (18%) 37 (82%) 3.340 0.006 0.965 0.955
Believes the medicine protects against malaria 12 (15%) 69 (85%) 8.886 <0.001 2.364 0.194
population may be critical to maximize village participation 
in this setting. To achieve high coverage the purpose of the 
intervention must be understood by the entire community.
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